TAK Takeda Pharmaceutical Company Limited
18.37USD+1.49%Mkt Cap: 58.68B $P/E: —1d ago
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products. It offers pharmaceutical products in the areas of gastroenterology, rare d…
Industry Peers
Drug Manufacturers - Specialty & Generic$66.23BUSDP/E 25.7
$45.70BUSDP/E 65.3
GALD
Galderma Group AG$43.27BUSDP/E 56.1
$39.67BUSDP/E 18.4
SDZ
Sandoz Group AG$34.93BUSDP/E 60.5
HLN
Haleon plc$32.73BUSDP/E 19.0
$29.57BUSDP/E 11.8
$28.56BUSDP/E 12.2
$23.38BUSDP/E 19.5
$20.09BUSD
$14.43BUSDP/E 112.9
$14.58BUSDP/E 21.0
$12.99BUSDP/E 23.5
$11.17BUSD
$10.22BUSDP/E 27.9
$8.66BUSDP/E 19.3
$6.95BUSDP/E 109.1
$6.89BUSD
$6.84BUSDP/E 40.1
HLUN-B
H. Lundbeck A/S$6.51BUSDP/E 11.5
Key Statistics
Company
Market Cap58.68B USD
Enterprise Value5.13T USD
Revenue (TTM)4.62T USD
Gross Profit2.93T USD
Net Income (TTM)-152.39B USD
Revenue/Share1462.74 USD
Last Price18.37 USD
Fiscal Year EndMar 2026
MR QuarterJun 2026
Employees47.0K
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)34.15
PEG0.40
EV/EBITDA4.11
EV/Revenue1.11
P/S0.01
P/B1.19
EPS (TTM)-0.34
EPS (Forward)0.53
52W Range
12.9988% of range19.10
52W High19.10 USD
52W Low12.99 USD
Profitability
Gross Margin65.12%
Oper. Margin16.45%
EBITDA Margin27.05%
Profit Margin-3.38%
ROE-2.05%
ROA-0.98%
Growth
Revenue Growth10.20%
Earnings Growth-9.80%
Cash Flow & Leverage
Operating CF1.04T USD
CapEx (TTM)414.66B USD
FCF Margin11.72%
FCF Yield922.64%
Net Debt5.08T USD
Net Debt/EBITDA4.06
Balance Sheet
Debt/Equity0.66
Current Ratio1.14
Quick Ratio0.51
Book Value/Sh15.15 USD
Cash/Share145.85 USD
Dividends
Fwd Div Rate0.62 USD
Trail. Div Rate200.00 USD
Div. Yield3.46%
5Y Avg Yield4.42%
Payout Ratio279.89%
Ex-Div DateMar 31, 2026
Pay DateJul 6, 2026
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)21.94 USD
Upside (mean)+19.4%
Target Range20.94 USD – 22.86 USD
20.94+19.4% to mean22.86
# Analysts3
Ownership
Shares Out.3.19B
Float3.16B
Insiders0.07%
Institutions3.31%
Short Interest
Short Ratio1.9d
Short % Float0.13%
Short % Out.0.13%
Shares Short4.20M
Short (prev mo.)2.99M
Technical
SMA 5018.04 (+1.8%)
SMA 20017.18 (+6.9%)
Beta0.10
S&P 52W Chg15.78%
Avg Vol (30d)2.22M
Avg Vol (10d)2.45M
Technical Indicators
RSI (14)51.5
MACD-0.0106
MACD Signal0.0950
MACD Hist.-0.1056
BB Upper19.30 USD
BB Middle18.50 USD
BB Lower17.70 USD
BB Width8.69%
ATR (14)0.2918 USD
Vol Ratio (20d)1.08x